Box prices IPO at $14, above the range
Box,
which provides enterprises with a cloud-based storage and collaboration
platform, raised $175 million by offering 12.5 million shares at $14,
above the range of $11 to $13. Box plans to list on the NYSE under the
symbol BOX.
Box initially filed confidentially on 1/3/2014. Morgan Stanley, Credit
Suisse and J.P. Morgan acted as lead managers on the deal.
Breast cancer biotech Syndax Pharmaceuticals withdraws $60 million IPO
Syndax Pharmaceuticals, a late-stage biotech developing a novel therapy for treatment-resistant breast cancer, withdrew its plans for an initial public offering on Thursday.
In June 2014, the company filed to raise $60 million at a fully diluted market value of $179 million, but postponed its offering. In November 2014, it refiled with blank terms and updated financials for September 30, 2014.
Another cancer biotech is on the IPO calendar to price next week - TRACON Pharmaceuticals (TCON).
Based in Waltham, MA, TRACON was founded in 2005 and planned to list on the NASDAQ under the symbol SNDX. Deutsche Bank and Jefferies were set to be the joint bookrunners on the deal.
Keep an eye on it: Inotek Pharmaceuticals sets terms for $65 million IPO
Inotek
Pharmaceuticals, a biotech developing a small molecule eye drop therapy
to treat glaucoma, announced terms for its IPO on Thursday. The
Lexington, MA-based company plans to raise $65 million by offering 4.6
million shares at a price range of $13 to $15. At the midpoint of the
proposed range, Inotek Pharmaceuticals would command a fully diluted
market value of $200 million.
Inotek Pharmaceuticals, which was founded in 1999, plans to list on the NASDAQ under the symbol ITEK. Cowen & Company, Piper Jaffray, Canaccord Genuity and Nomura Securities are the joint bookrunners on the deal. It is expected to price during the week of February 2, 2015.
Inotek Pharmaceuticals, which was founded in 1999, plans to list on the NASDAQ under the symbol ITEK. Cowen & Company, Piper Jaffray, Canaccord Genuity and Nomura Securities are the joint bookrunners on the deal. It is expected to price during the week of February 2, 2015.
Blogger Comment
Facebook Comment